Picture of Pulmonx logo

LUNG Pulmonx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Pulmonx Corp expected to post a loss of 40 cents a share - Earnings Preview

Pulmonx Corp LUNG.OQ LUNG.O is expected to  show a rise in quarterly revenue when it reports  results on July 30 for the period ending June 30 2025

The Redwood City California-based  company is expected to report a 12.9% increase in revenue to $23.468 million from $20.78 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Pulmonx Corp is for a loss of 40 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Pulmonx Corp is $13.50, about 75.3% above its last closing price of $3.34

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDINGSTARMINESMARTESTIMATE®LSEG IBES ESTIMATEACTUALBEAT, MET, MISSEDSURPRISE %
Mar. 31 2025-0.39-0.40-0.36Beat10
Dec. 31 2025-0.44-0.45-0.33Beat26.3
Sep. 30 2024-0.45-0.45-0.36Beat19.7​
Jun. 30 2024-0.42-0.43-0.35Beat17.7
​​Mar. 31 2024-0.45-0.46-0.36Beat22
Dec. 31 2023-0.38-0.41-0.36Beat11.6​
Sep. 30 2023-0.42-0.43-0.39Beat8.8
Jun. 30 2023-0.44-0.44-0.43Beat1.6
This summary was machine generated July 28 at 20:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Recent news on Pulmonx

See all news